Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.
about
Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trialsCurrent and emerging treatment strategies for Duchenne muscular dystrophyMuscle injuries and strategies for improving their repairThe emerging role of viral vectors as vehicles for DMD gene editingDental and Nondental Stem Cell Based Regeneration of the Craniofacial Region: A Tissue Based ApproachIncreased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell ImagingDystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesHuman myogenic reserve cells are quiescent stem cells that contribute to muscle regeneration after intramuscular transplantation in immunodeficient micePharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.Nitric Oxide Donor Molsidomine Positively Modulates Myogenic Differentiation of Embryonic Endothelial Progenitors.piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx Mice.Emerging new tools to study and treat muscle pathologies: genetics and molecular mechanisms underlying skeletal muscle development, regeneration, and disease.Sodium Iodide Symporter PET and BLI Noninvasively Reveal Mesoangioblast Survival in Dystrophic MiceMuscle Interstitial Cells: A Brief Field Guide to Non-satellite Cell Populations in Skeletal Muscle.Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.Pericytes and their potential in regenerative medicine across species.Myogenic progenitor specification from pluripotent stem cells.Aging affects the in vivo regenerative potential of human mesoangioblasts.Perfusion decellularization of a human limb: A novel platform for composite tissue engineering and reconstructive surgery.Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.Muscle MRI of classic infantile pompe patients: Fatty substitution and edema-like changes.In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.Isolation and Characterization of Vessel-Associated Stem/Progenitor Cells from Skeletal Muscle.Whole Organ Tissue Vascularization: Engineering the Tree to Develop the Fruits.At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients?Gene and Cell Therapy for Muscular Dystrophies: Are We Getting There?
P2860
Q26741409-C71C365F-B92C-46F2-AE3C-93D28471F6EEQ26741535-993E5143-F292-47D3-9381-6FCFFA2A8FB3Q26742069-4D472A57-B3EB-434A-B34A-402003103531Q26746647-05967D0F-2DBD-4B6E-B468-B0F61C39FDF2Q26752898-93ED544A-9161-4A71-8574-CD2BA93A00F4Q26753150-470545B6-9622-4E5B-9CFE-464D39A74DC7Q33608478-63C2BB26-8B5B-432D-8FE8-CDDE5467F7E5Q33799526-9D7B31A1-8B8F-454D-8A3A-A8DC90A84196Q33809437-CF17DFD5-1F4D-438E-9000-EAC3B5062BDFQ36168025-A4977CF8-EC5A-4415-8657-1E2C46B5DB9AQ36532676-28B100A4-8320-429F-94A5-7AA9A0640738Q37718154-49A2B5F6-FB5D-4ABD-8072-1E94086F8CE6Q38808814-C363CFC2-A752-4E00-BC32-A04BF83BF866Q38815247-2B75AEA5-C5EB-4E82-A2AE-99C4784343E1Q39155795-C9A2966C-E746-48D6-A121-5AE1E001775FQ42859445-CF20476A-4EA4-4494-89B4-0A5DED540C52Q45875854-62492642-1644-4A17-90E7-E28776DC9D2AQ46190014-FD9E660C-25FB-4E03-B677-385F09320A8DQ46302140-1188FDF6-10A2-43AD-9158-EA7745B838FBQ47286671-8D835598-02F3-4E2C-950B-0760A21849A6Q48110095-A44781E5-5BD2-4B7C-AEFF-89F649EA53C6Q48203777-B6EC68ED-BD10-4CD8-9E94-D7BE753F8DEBQ48223753-4ECC1B18-BBB0-42D3-A287-20F23B09B9F1Q48300126-96EDB3C6-DD75-428D-A5CB-75A82B8B37D5Q48495872-98A20BD4-8FEA-43E9-808E-E5B1D357C6ACQ50233651-D8FF537F-CF93-4217-A145-B34BC6FC0DBAQ52714547-B9E7415B-828E-405A-B469-0FE68D23FB92Q52899792-32CCEC46-7C06-4E3F-AA8A-AE09C2BEE1C5Q54996988-EEEC0DC4-F1EA-46B9-AE3E-0E74236F80E3Q55361250-94068389-89EC-4CFC-9FF4-6451CB93BE17Q58738445-99898C95-546F-4327-B366-8BFBAEC6C974
P2860
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@ast
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@en
type
label
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@ast
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@en
prefLabel
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@ast
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@en
P2093
P2860
P50
P356
P1476
Intra-arterial transplantation ...... n Duchenne muscular dystrophy.
@en
P2093
Andrea Tettamanti
Benedetta Mazzi
Cristina Rivellini
Fabio Ciceri
Francesca Ciotti
Francesca Nicastro
Giuseppina Marano
Isabella Lorenzetti
Maddalena Noviello
Maria Adele Imro
P2860
P304
P356
10.15252/EMMM.201505636
P50
P577
2015-11-05T00:00:00Z